Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Houston TX, Dallas TX, Atlanta GA, Knoxville TN,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

for
Lung Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04595422

Recruiting

ORB-021 In Patients With Advanced Solid Tumors

for
Advanced Solid Tumors Cancer
Location: Houston TX, Scottsdale AZ
Sponsor: Orionis Biosciences Inc

Sex: All

Age: 18+

Code: NCT06607939

Phase 1, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Houston TX, Bellaire TX, Longview TX, Dallas TX,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

for
Stem Cell
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06004063

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)

for
Phase 1b, HC-7366, SHARK, Kidney Cancer
Location: Houston TX, Dallas TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07401875

Phase 1, Recruiting

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

for
Thyroid Carcinoma
Location: Houston TX, Sarasota FL
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07218315

Recruiting

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

for
Medullary Thyroid Cancer (MTC), Cultural Adaptation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07142005

Recruiting

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

for
Lu-177 PSMA
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 0+

Code: NCT07169825

Recruiting

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06085729

Phase 1, Phase 2, Recruiting

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

for
Urinary Tract Infection
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: Male

Age: 0

Code: NCT07508124

Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Houston TX, Austin TX, San Antonio TX, Fort Worth TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase 1, Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for
Acute Promyelocytic Leukemia (APL),
Location: Houston TX, Birmingham AL, Nashville TN, Augusta GA,
Sponsor: Quetzal Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07504458

Phase 3, Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Houston TX, Nashville TN, Tampa FL, Denver CO,
Sponsor: Prelude Therapeutics Incorporated

Sex: All

Age: 18+

Code: NCT07469891

Phase 1, Recruiting

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

for
Type 2 Diabetes
Location: Houston TX, Missouri City TX, Austin TX, San Antonio TX,
Sponsor: Biomea Fusion Inc.

Sex: All

Age: 18 - 70+

Code: NCT07502508

Phase 2, Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Houston TX, Indianapolis IN, Detroit MI, Fairfax VA,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase 1, Phase 2, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Houston TX, Tyler TX, Mobile AL, Atlanta GA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase 2, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Houston TX, Galveston TX, San Antonio TX, Daphne AL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

for
Gastric Adenocarcinoma, Oligometastasis,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03161522

Phase 2, Recruiting

Knee Flexionater to Avoid Motion Restoring Surgery

for
Joint Contractures, Total Knee Anthroplasty,
Location: Houston TX
Sponsor: Ermi LLC

Sex: All

Age: 40+

Code: NCT07454356

Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City